Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1150 results found. Search for [ Cipla ]

Results 1120 to 1140 of 1150
Rahul Sachitanand
June 9, 2010
Most of our earlier start-up listers thrive, except for a few that stumbled.


Suman Layak
May 26, 2010
For most of its 40 years, Lupin seemed to be just another Indian pharma company trying to make hay in the US generics market. Today, it is a global generics firm to reckon with, taking on giant Teva on the value-creation front.


www.businesstoday.in
September 22, 2020



www.businesstoday.in
July 25, 2020



www.businesstoday.in
September 3, 2009
There’s clearly a healthy jostle for space in our monthly ranking of “India’s Most Watched Ads” as it’s not always the big spending FMCG sector that tops the most watched list.


E. Kumar Sharma
August 19, 2009
By refocussing its strategies, Natco Pharma has pulled back from the brink of bankruptcy to power ahead in cancer drugs. Now it is looking for niche areas globally. Can it scale up and take on global competition?


Edwin Naidu
June 17, 2009
The just-concluded IPL 2 looks set to usher in a vigorous engagement between Indian and South African businesses.


www.businesstoday.in
May 14, 2009
Indian pharma companies say they are geared to meet the global demand for the antidote to H1N1 infection.


Shamni Pande
March 5, 2009
In businesses, big or small, ranging from manufacturing to music, the fight for intellectual property is getting intense. Neglect it and you could be out of business.


Anand Adhikari
February 5, 2009
Close to half of the cream of India Inc. prefers to have lesser-known auditors.


Virendra Verma
November 13, 2008
After years of rollicking appreciation, companies that make up the BT 500 are going through one of their toughest phases in a long, long time. As stocks get mercilessly hammered, this may just be the time when the men are separated from the boys. Virendra Verma reports.


Suman Layak
August 20, 2008
Drugs, diagnostics, real estate, private equity and glass may seem a motley bunch of businesses, but it doesn’t matter how diverse your portfolio is if you can emerge top dog. And it’s leadership that Ajay Piramal is aiming for, reports S. Layak.


www.businesstoday.in
August 6, 2008
After Daiichi Sankyo’s purchase of Ranbaxy Labs, Teva Pharma, the world’s largest generics company, acquired Barr Pharma, the US’ fourth largest generics firm. There are two questions on pharma analysts’ lips these days: Who’s next? Are Indian generics players targets for pharma MNCs?


www.businesstoday.in
July 23, 2008
Appointed: R.S. Pandey, as the new Petroleum Secretary. He replaces M.S. Srinivasan, who retires on July 31. Pandey, a 1972-batch IAS officer from the Nagaland cadre, is the Steel Secretary at present. Pandey will have a 17-month stint as the Secretary, Ministry of Petroleum and Natural Gas.


www.businesstoday.in
June 26, 2008
The takeover of India’s best-known drug maker, Ranbaxy Laboratories, by Japanese innovator company, Daiichi Sankyo, may have evoked a sense of disbelief all around.


E Kumar Sharma
June 25, 2008
A healthy dose of pharma stocks in your portfolio can be a good defensive strategy in this volatile market.


E. Kumar Sharma
June 24, 2008
Several Indian drug makers seem ripe for the picking, but buyers will have to come up with compelling offers.


www.businesstoday.in
June 24, 2008
Resigned: Vinod Dhall, as Acting Chairman of the Competition Commission of India. The Ministry of Corporate Affairs, of which CCI is a part, recently advertised for the position of Chairman and five other members of the CCI board.


www.businesstoday.in
April 2, 2008
If there’s one human trait that has seen mankind through the Earth’s tumultuous history, it is the ability to innovate.


Sanjoy Narayan
April 20, 2008
Look at some of the most successful corporations around the world, and you'll find one thing that's common to them: they are innovative. To find out the state of innovation in India, Business Today tied up with the Monitor Group. The results of our study are fascinating.


PAGES 57 OF 58  565758